INDEPENDENT PEPTIDE RESEARCH
The Vial Files.
Decode the vial. Master the Math.
Peptide research, dosing evidence, and safety context — brought together in one source-linked library.
46 compound files
Mechanisms, findings & studies
Research in context
Experimental ≠ established
Evidence, not guesswork
Sources & safety limitations
Precision tools
Peptide & TDEE calculators
THE RESEARCH INDEX
Peptide protocol library46 files
Orbitrex catalog · October 18, 2026
46 files · All categories
Source-linked research5-amino-1mq
Non-peptide research compound. No established human self-dosing protocol.
Adamax
Experimental modified peptide; human safety and dosing are not established.
AOD-9604
Growth hormone fragment investigated in metabolic research.
ARA-290
Erythropoietin-derived peptide investigated in tissue-protection research.
Buffered NAD+
Non-peptide research compound. No established human self-dosing protocol.
Cagrilintide
Long-acting amylin analog investigated for weight management.
Cartalax
Short peptide studied in cell and tissue research.
CJC-1295 (no DAC) + IPA
Growth-hormone signaling peptide blend. Combination dosing is not clinically established.
Cortagen
Short peptide investigated in neurological research.
DSIP
Delta sleep-inducing peptide investigated in sleep-related research.
Epithalon
Experimental tetrapeptide explored in aging and cellular research.
FOXO4-DRI
Experimental senolytic peptide; preclinical findings do not establish human dosing.
GLOW 70
Multi-peptide research blend. Verify each constituent against batch documentation.
Glutathione
Tripeptide antioxidant involved in cellular redox regulation.
Ipamorelin
Growth hormone secretagogue investigated in endocrine research.
Kisspeptin
Peptide involved in reproductive hormone signaling.
KLOW
Multi-peptide blend; combined safety and human dosing are not established.
KPV
Tripeptide investigated in inflammation-related preclinical research.
LL-37
Antimicrobial peptide with immune-signaling activity and important safety uncertainties.
Melanotan I
Melanocortin agonist associated with afamelanotide research. The community identifies MT-1 as Melanotan I; research powder is not equivalent to a licensed implant.
Melanotan II
Experimental melanocortin agonist. No established safe self-use regimen.
MOTS-C
Mitochondrial-derived peptide investigated in cellular metabolism.
N-Acetyl Selank Amidate
Modified Selank analog. Evidence for Selank cannot establish dosing for this derivative.
N-Acetyl Semax Amidate
Modified Semax analog. Parent-compound protocols are not transferable.
NAD+
Non-peptide research compound. No established human self-dosing protocol.
Orbitzen 40
Recovery blend of BPC-157, TB-500 and KPV.
Oxytocin
Peptide hormone with prescription medical uses requiring indication-specific supervision.
PE-22-28
Experimental peptide explored in neurobiological research.
Pinealon
Short peptide investigated in cellular and neurological research.
PT-141
Bremelanotide: prescription-label information exists for Vyleesi, not for research vials.
Retatrutide
Investigational GIP, GLP-1 and glucagon receptor agonist studied for obesity.
Selank
Synthetic peptide investigated in anxiety-related research.
Semaglutide
GLP-1 receptor agonist studied for weight management and type 2 diabetes.
Semax
Synthetic peptide studied in neurological research; regulatory status varies by country.
Sermorelin
Growth hormone-releasing hormone analog with endocrine research history.
SLU-PP-332
Non-peptide research compound. No established human self-dosing protocol.
SomatoPulse
1:1 Ipamorelin + Tesamorelin growth hormone blend.
SS-31
Elamipretide, a mitochondria-targeting peptide studied in mitochondrial disorders.
Survodutide
Investigational glucagon / GLP-1 receptor agonist studied in clinical trials.
TB-500
Thymosin-related research peptide; full-length thymosin β4 findings may not apply.
Tesamorelin
Growth hormone-releasing factor analog studied for excess abdominal fat in HIV-associated lipodystrophy.
Thymosin Alpha-1
Immune-modulating peptide with jurisdiction-specific clinical research and use.
Tirzepatide
Dual GIP / GLP-1 receptor agonist studied for weight management and type 2 diabetes.
Vilon
Experimental short peptide investigated in cellular research.
VIP
Vasoactive intestinal peptide involved in vascular and immune signaling.
Wolverine
Research peptide blend. Component studies do not establish a safe combined regimen.
THE NUMBERS MATTER
Less guesswork. More clarity.
Concentration calculations and daily energy estimates.